MODERNA likens “messenger” RNA, or mRNA, to a form of software for life, providing information to every cell in the body. Over the past decade, the Massachusetts-based company has pioneered mRNA science to create transformative medicines with its tech platform, world-class team and high-acceleration infrastructure. Moderna has 24 products in development, with 13 in clinical studies. It was part of the select group of pharmaceutical companies and academic researchers to crack the Covid challenge, advancing global vaccination efforts. The BV judging panel declares Moderna the 2021 winner of the award for Most Innovative Biotech Solutions (US).